Ambarella, Inc. (AMBA) – Quantitative Financial Prediction

AMBA – Increase Expected (5-day)

Ambarella develops low-power SoCs and AI processors for edge applications. Revenue growth is strong (37% YoY), but GAAP net income remains negative. Non-GAAP earnings are positive, and free cash flow is healthy. The stock trades at a forward P/E of 63.3, reflecting growth expectations.

Ambarella’s Q1 earnings met estimates, revenue surged 16.9% YoY, and the company announced a massive $800M+ long-term agreement with Hanwha. With Q2 guidance pointing to sequential growth and a $50M buyback approved, the stock appears poised for a short-term upward move.

Why This Matters

The semiconductor sector is highly cyclical, and Ambarella’s pivot to edge AI and automotive is a key growth driver. The Hanwha deal underscores long-term revenue visibility, while the Q2 guidance provides a near-term catalyst. Investors should watch for continued execution in IoT and robotics.

Key Insights

• Revenue grew 37% YoY to $390.7M, driven by automotive and edge AI strength.
• GAAP net income is negative (-$75.86M), but non-GAAP EPS was $0.11 in Q1, showing underlying profitability.
• Free cash flow is positive at $58.01M, supporting the new $50M share repurchase program.
• High beta (2.16) indicates elevated volatility, which could amplify short-term moves.
• Analyst consensus is ‘buy’ with an average price target of $87.92, 22% above the current price.

Catalyst Analysis

The primary catalyst is Ambarella’s Q1 FY2027 earnings release (May 28, 2026) and the accompanying Q2 guidance of $105M–$111M in revenue, implying sequential growth of 4.6%–10.6%. Additionally, the long-term Hanwha agreement (potentially >$800M over 10+ years) provides a strategic growth narrative. The $50M buyback adds a supportive capital allocation signal. These catalysts are capable of driving a 5%+ move in the stock over the next 5 days as the market digests the earnings beat and forward outlook.

Signal Contradictions

No major contradictions exist. The bullish news sentiment (67%) aligns with the positive earnings and guidance. The RSI of 46.27 is neutral, not bearish. The only potential contradiction is the gap between strong revenue growth (37%) and negative GAAP net margin (-19.42%), but this is typical for high-growth semiconductor companies investing in R&D. Non-GAAP profitability and positive free cash flow mitigate this concern.

Margin & Efficiency Analysis

Gross margin is healthy at 59.19%, and the company targets 59%–62% long-term. However, net margin is deeply negative (-19.42%), reflecting high operating expenses (R&D, sales, and marketing). The gap between gross and net margin is 78.6 percentage points, indicating significant operational leverage potential. As revenue scales, net margins should improve. The Q1 non-GAAP gross margin of 59.9% is within the target range, suggesting cost control is on track.

Practical Implications

• Bull Case: Revenue growth accelerating (37% YoY) with a clear path to profitability via non-GAAP earnings. The Hanwha deal provides a multi-year revenue backlog. Q2 guidance implies continued momentum. Analyst target of $87.92 offers 22% upside. Positive free cash flow and a new buyback program support shareholder returns.
• Bear Case: GAAP net income remains negative, and the company has a history of losses. High beta (2.16) makes the stock vulnerable to market downturns. The forward P/E of 63.3 is elevated, leaving little room for error. If Q2 guidance disappoints or the Hanwha deal takes longer to materialize, the stock could correct.
• Sideways Risk: The RSI of 46.27 is in the neutral zone (45–55), which could lead to sideways trading if the market is unimpressed by the earnings. However, the presence of a clear catalyst (Q2 guidance, Hanwha deal) overrides the sideways default rule. The risk of sideways movement is low given the positive sentiment and analyst upgrades.
• Confidence: 7/10 – Confidence is 7/10. Recent news (within 1 day) is highly relevant (relevance scores 10) and predominantly bullish (67%). The financial data shows strong revenue growth, positive free cash flow, and a healthy balance sheet (low debt/equity of 0.02). The analyst consensus is ‘buy’ with a target well above current price. The only drags are the stale article (185 days old, but not influential) and the negative GAAP net income, which is offset by non-GAAP profitability. The RSI is neutral, but the catalyst is strong enough to drive a short-term increase.

Prediction (5-day): increase

---

Analysis Metadata:

• News Collection: 2026-05-29
• Analysis Date: 2026-05-29
• Target Date: 2026-06-03

References:

• https://finance.yahoo.com/quote/AMBA/
• https://finance.yahoo.com/markets/stocks/articles/ambarellas-q1-earnings-meet-estimates-140700679.html
• https://investor.ambarella.com/news-releases/news-release-details/ambarella-inc-announces-third-quarter-fiscal-year-2026-financial